IMI - Call 17

The Innovative Medicines Initiative has published three  future topics for their 17th call. The deadline is not announced yet.

The Innovative Medicines Initiative (IMI) is a partnership between the European Union and the European pharmaceutical industry. IMI facilitates open collaboration in research to advance the development of, and accelerate patient access to, personalised medicines for the health and wellbeing of all, especially in areas of unmet medical need.

Call 17

The following topics are under consideration for inclusion in the next IMI Call for proposals:

Link to IMI

About IMI2

The content of this article may still change dependent on changes in the final call.

Published Oct. 19, 2018 1:40 PM - Last modified Oct. 22, 2018 2:17 PM